Articles from Telomir Pharmaceuticals, Inc.

Telomir Announces Peer-Reviewed Publication Demonstrating Telomir-Zn Suppresses Tumor Growth in TNBC and Prostate Cancer Models

Iron-Rescue Experiments Confirm Iron-Dependent Mechanism. Tumor Suppressor Gene Reactivation and Anti-Tumor and Anti-Metastatic Activity Across Multiple Models.

By Telomir Pharmaceuticals, Inc. · Via GlobeNewswire · August 10, 2026